Dr. Christine Toni Charaf, MD

Dr. Charaf practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Dr. Charaf's NPI, 1962795237, was assigned on May 19, 2011. Dr. Charaf holds Georgia license 072743.

Dr. Charaf's primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Dr. Charaf's primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. The medical group on file is Grady Health System. Dmand AI also links Dr. Charaf to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Charaf practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Charaf's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Charaf is licensed in Georgia.

CMS data shows 44 Medicare services from Dr. Charaf across 1 procedure code in 2024, all of them office visits, for 65 Medicare patients. Medicare paid $1,674 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Charaf in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 69% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Charaf's median patient age at 68, with 53% women.

In 2024, Dr. Charaf wrote 1,127 Medicare Part D claims for 271 patients. 74% of them were for generic drugs. CMS names the drug for 753 of them, across 29 drugs with 11 or more claims each, at $79,719 in total drug cost. In 2023, CMS named 469 claims across 18 drugs.

Dr. Charaf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Charaf from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $180.